Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

Caitlin E. Cox

December 28, 2023

News Daily News

Reduced EF Evident in Some Elite Endurance Athletes

Michael O'Riordan

December 21, 2023

News Daily News

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Caitlin E. Cox

December 12, 2023

News Conference News AHA 2023

Sudden Cardiac Death Declining Among NCAA Athletes

Michael O'Riordan

November 15, 2023

News Conference News AHA 2023

AI Improves Detection of Cardiomyopathy in Pregnancy

L.A. McKeown

November 15, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

L.A. McKeown

October 12, 2023

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Study Finds No Increased Risk of CVD Years After Infertility Therapies

L.A. McKeown

August 11, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Shelley Wood

July 19, 2023

News Daily News

ATTRibute-CM Top-Line Results Favorable for Acoramidis

L.A. McKeown

July 17, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

CVD Risks After Pregnancy Linked to Prenatal Depression

L.A. McKeown

April 21, 2023

News Daily News

CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors

Yael L. Maxwell

April 13, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2023

Reduced EF Evident in Some Elite Endurance Athletes

Millions of Lives Lost to CVD Each Year: ‘Almanac’ Updates Global Burden

Sudden Cardiac Death Declining Among NCAA Athletes

AI Improves Detection of Cardiomyopathy in Pregnancy

What’s Going to Be Hot at AHA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

September 2023 News Roundup

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

What’s Going to Be Hot at ESC 2023?

Study Finds No Increased Risk of CVD Years After Infertility Therapies

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

ATTRibute-CM Top-Line Results Favorable for Acoramidis

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

CVD Risks After Pregnancy Linked to Prenatal Depression

CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content